BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2982482)

  • 1. Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lung.
    Bernal SD; Mabry M; Stahel RA; Griffin JD; Speak JA
    Cancer Res; 1985 Mar; 45(3):1026-32. PubMed ID: 2982482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane antigen in small cell carcinoma of the lung defined by monoclonal antibody SM1.
    Bernal SD; Speak JA
    Cancer Res; 1984 Jan; 44(1):265-70. PubMed ID: 6317170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody.
    Okabe T; Kaizu T; Ozawa K; Urabe A; Takaku F
    Cancer Res; 1985 May; 45(5):1930-3. PubMed ID: 2985239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
    Stahel RA; Mabry M; Sabbath K; Speak JA; Bernal SD
    Int J Cancer; 1985 May; 35(5):587-92. PubMed ID: 2987136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic murine monoclonal antibody LAM8 with specificity for human small cell carcinoma of the lung.
    Stahel RA; O'Hara CJ; Mabry M; Waibel R; Sabbath K; Speak JA; Bernal SD
    Cancer Res; 1986 Apr; 46(4 Pt 2):2077-84. PubMed ID: 3004719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of SM-1 monoclonal antibody and human complement in selective killing of small cell carcinoma of the lung.
    Mabry M; Speak JA; Griffin JD; Stahel RA; Bernal SD
    J Clin Invest; 1985 May; 75(5):1690-5. PubMed ID: 2987309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
    Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
    Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
    Elias AD; Pap SA; Bernal SD
    Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective depletion of human myeloma clonogenic stem cells from bone marrow cell preparations by a plasma-cell reactive antibody and complement.
    Stone MJ; Tong AW; Fay JW; Lee JC
    Cancer Detect Prev; 1988; 12(1-6):621-35. PubMed ID: 3180147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of antigens associated with small cell carcinoma of the lung on hematopoietic progenitor cells.
    Ball ED; Keefe KA; Colby E
    Cancer Res; 1987 Dec; 47(24 Pt 1):6556-9. PubMed ID: 2824035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis.
    Cheresh DA; Rosenberg J; Mujoo K; Hirschowitz L; Reisfeld RA
    Cancer Res; 1986 Oct; 46(10):5112-8. PubMed ID: 3019521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel monoclonal antibody-defined antigen which distinguishes human non-small cell from small cell lung carcinomas.
    Sobol RE; Peters RE; Astarita RW; Hofeditz C; Masui H; Burton D; Handley HH; Glassy MC; Fairshter R; Carlo DJ
    Cancer Res; 1986 Sep; 46(9):4746-50. PubMed ID: 3015395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement depletion in vitro limits monoclonal antibody 6-19-dependent complement-mediated killing of tumor cells in bone marrow.
    Duerst RE; Rose D; Frantz CN
    Exp Hematol; 1991 Oct; 19(9):863-7. PubMed ID: 1893961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to surface antigens of small cell carcinoma of the lung.
    Okabe T; Kaizu T; Fujisawa M; Watanabe J; Kojima K; Yamashita T; Takaku F
    Cancer Res; 1984 Nov; 44(11):5273-8. PubMed ID: 6091874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
    Kinouchi T; Bander NH; Kotake T
    J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro.
    Bieber MM; Twist CJ; Bhat NM; Teng NN
    Pediatr Blood Cancer; 2007 Apr; 48(4):380-6. PubMed ID: 16421902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of monoclonal antibodies to diagnosis and treatment of small cell lung cancers].
    Fujisawa M; Okabe T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):984-9. PubMed ID: 2839119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.